PepGen (PEPG) Earnings Date & Reports

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PEPG is expected to report earnings to rise 5.88% to -72 cents per share on June 12

Q1'25

Est.

$-0.72

Q4'24

Beat

by $0.13

Q3'24

Beat

by $0.21

Q2'24

Missed

by $0.15

Q1'24

Beat

by $0.13

The last earnings report on February 24 showed earnings per share of -68 cents, beating the estimate of -81 cents. With 56.00K shares outstanding, the current market capitalization sits at 54.92M.

View a ticker or compare two or three

Compare

PEPG